ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

Smoking Increases Breast Cancer Risk Based on Genes

February 29, 2008

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977